Cathepsin D in ovarian cancer:: prognostic value and correlation with p53 expression and microvessel density

被引:51
|
作者
Lösch, A
Schindl, M
Kohlberger, P
Lahodny, J
Breitenecker, G
Horvat, R
Birner, P
机构
[1] Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Gynecol & Obstet, A-1090 Vienna, Austria
[3] Hosp St Polten, Dept Gynecol & Obstet, A-3100 St Polten, Austria
关键词
cathepsin D; ovarian cancer; prognosis; p53; angiogenesis;
D O I
10.1016/j.ygyno.2003.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Overexpression of ubiquitous lysosomal aspartyl protease cathepsin D (CD) is involved in the progression of cancer. This study investigates the prognostic value and the association of cathepsin D expression with clinicopathological parameters, p53 expression, and angiogenesis in ovarian cancer. Methods. Cathepsin D was determined immunohistochemically in 43 ovarian tumors of low malignant potential (LMP) and 80 invasive tumors FIGO stage I-IV. Results were correlated with clinicopathological characteristics, p53, and microvessel density (MVD). Survival analysis of cathepsin D expression and MVD was performed in invasive tumors. Results. Epithelial tumor cathepsin D expression was more common in LMP tumors (65.1%) compared to invasive tumors (43.7%; P = 0.02). In LMP tumors, stromal cathepsin D was associated with mucinous tumors (P = 0.01), whereas in invasive tumors, epithetial cathepsin D expression was associated with clear cell tumors (P = 0.003). Invasive tumor cathepsin D had a negative relation to p53 expression. In LMP tumors, stromal cathepsin D correlated with microvessel density (P = 0.03). Stromal cathepsin D expression was an independent prognostic factor for disease-free survival (DFS) in patients with invasive cancer (P = 0.03, Cox regression), while cathepsin D expression missed to be of prognostic value for overall survival (OS) in invasive ovarian cancer. MVD had no influence on survival in invasive ovarian cancer (P > 0.05). Conclusion. Our study demonstrates a prognostic value of cathepsin D expression in invasive ovarian cancer, while cathepsin D expression in LMP rumors seems to be linked to angiogenesis. The relation among cathepsin D, p53 expression, and angiogenesis demonstrates biological differences between invasive ovarian cancer and LMP tumors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [21] P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer
    Sagarra, RAM
    Andrade, LALA
    Martinez, EZ
    Pinto, GA
    Syrjänen, KJ
    Derchain, SFM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) : 720 - 727
  • [22] Prognostic value of p53 protein expression for patients with gastric cancer - a multivariate analysis
    Maehara, Y
    Tomoda, M
    Hasuda, S
    Kabashima, A
    Tokunaga, E
    Kakeji, Y
    Sugimachi, K
    BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) : 1255 - 1261
  • [23] Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer
    Marx, D
    Meden, H
    Ziemek, T
    Lenthe, T
    Kuhn, W
    Schauer, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 845 - 850
  • [24] Prognostic value of cytosolic p53 protein in breast cancer
    Montero, S
    Guzmán, C
    Vargas, C
    Ballestín, C
    Cortés-Funes, H
    Colomer, R
    TUMOR BIOLOGY, 2001, 22 (05) : 337 - 344
  • [25] Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density
    Raymond Miralbell
    Markus Tolnay
    Sabine Bieri
    Alphonse Probst
    André-Pascal Sappino
    Willi Berchtold
    Michael S. Pepper
    Gianpaolo Pizzolato
    Journal of Neuro-Oncology, 1999, 45 : 103 - 110
  • [26] Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density
    Miralbell, R
    Tolnay, M
    Bieri, S
    Probst, A
    Sappino, AP
    Berchtold, W
    Pepper, MS
    Pizzolato, G
    JOURNAL OF NEURO-ONCOLOGY, 1999, 45 (02) : 103 - 110
  • [27] The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer
    Anttila, MA
    Ji, HX
    Juhola, MT
    Saarikoski, SV
    Syrjänen, KJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1999, 18 (01) : 42 - 51
  • [28] Expression of p53 in epithelial ovarian cancer
    Ozalp, S
    Yalcin, OT
    Minsin, TH
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (03) : 277 - 278
  • [29] Prognostic value of p53 accumulation in epithelial ovarian carcinomas
    Berker B.
    Dunder I.
    Ensari A.
    Cengiz S.D.
    Archives of Gynecology and Obstetrics, 2002, 266 (4) : 205 - 209
  • [30] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    Hofstetter, G.
    Berger, A.
    Fiegl, H.
    Slade, N.
    Zoric, A.
    Holzer, B.
    Schuster, E.
    Mobus, V. J.
    Reimer, D.
    Daxenbichler, G.
    Marth, C.
    Zeimet, A. G.
    Concin, N.
    Zeillinger, R.
    ONCOGENE, 2010, 29 (13) : 1997 - 2004